Journal article
Usefulness of Procalcitonin in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Crohn's & colitis 360, Vol.1(3), otz032
10/01/2019
DOI: 10.1093/crocol/otz032
Abstract
Background: Mixed results are reported for procalcitonin (PCT) as biomarkers of infection and disease activity in inflammatory bowel disease (IBD).
Method: We systematically evaluated and performed a meta-analysis on the usefulness of PCT in assessing infection and disease activity in IBD.
Results: The pooled standardized mean difference of PCT for those with infection compared with those without was 1.59 (95% CI, 0.72-2.46, P < 0.01) and those with active disease compared with those without was 1.22 (95% CI, 0.66-1.78, P < 0.01), respectively.
Conclusion: PCT may potentially be useful in differentiating an infectious process from IBD and active from inactive IBD.
Details
- Title: Subtitle
- Usefulness of Procalcitonin in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
- Creators
- Donna Ann Cheung - University of IowaLeonardo Tamariz - University of MiamiZsuzsanna Nemeth - University of MiamiAmber Hamid Langshaw - University of Miami
- Resource Type
- Journal article
- Publication Details
- Crohn's & colitis 360, Vol.1(3), otz032
- DOI
- 10.1093/crocol/otz032
- ISSN
- 2631-827X
- eISSN
- 2631-827X
- Publisher
- Oxford Univ Press
- Number of pages
- 7
- Language
- English
- Date published
- 10/01/2019
- Academic Unit
- Stead Family Department of Pediatrics; Gastroenterology, Hepatology, Pancreatology, and Nutrition
- Record Identifier
- 9984354003602771
Metrics
15 Record Views